Meet the 158 Biotech Ventures in Nucleate’s 2024 Activator Program

2 min readApr 7, 2024

Nucleate, the nonprofit organization dedicated to empowering future biotech leaders, announces 158 venture teams for its 2024 global Activator cycle.

During The Activator program, participating teams will focus on transforming their scientific discoveries into feasible business ideas. They will benefit from Nucleate’s exceptional network of experts, curated curriculum, legal assistance, and significant subsidized perks. Following a successful team formation period, they join the ranks of past Activator teams, including Manifold Bio ’19, Concerto Bio ’19, Glyphic Bio ’21, Kano Therapeutics ’21, and Range Biotech ‘22.

Meet the 2024 Activator teams:!

“Our mission is to empower the next generation of life science leaders and democratize life science education. With 158 venture teams from over 20 regions worldwide, we are staying true to that mission, and I couldn’t be more proud,” says Sammi Sison, Nucleate’s co-president.

At the end of the program, Activator teams will showcase their company ideas to the biotech community through a Demo Day Showcase. Register to attend your regional event here.

In the 2024 cycle, the Nucleate Activator teams are set to address a wide array of challenges, ranging from pioneering new medical treatments and AI-driven health improvements to eco-friendly solutions aimed at combating the climate crisis. They are exploring a diverse spectrum of innovative ideas to tackle pressing global issues.

Learn more about this cohort’s teams, who come from diverse, cutting-edge research entities and leading business schools around the world.

“This cohort’s technologies may transform medicine, agriculture, and other entire industries,” said Michael Retchin, Nucleate’s co-president. “But the talent behind them is even more transformative. We’re delighted to connect and empower them, helping these visionary academics launch their careers as entrepreneurs.”

If you are a life science company founder, executive, investor, or scientist interested in assisting Activator teams as a mentor or workshop expert, please register at

About Nucleate

Nucleate is a nonprofit organization dedicated to empowering the next generation of biotech leaders, with chapters spanning more than 30 regions and participation from over 120 academic institutions. Nucleate identifies future biotech entrepreneurs, removes barriers, and helps founders concentrate on building transformational technologies.

About Activator

Activator is a six-month, equity-free program designed for academic biotech founders. Its curriculum has served over 250 life sciences ventures that have raised over $320 million in venture funding. Alex Kim, MD-PhD Candidate at UCLA, is the Activator Global Head; and Julia Zhao, PhD, is the full-time Global Director of Activator Operations.

The Activator program is made possible thanks to our generous sponsors: (platinum) Alnylam, BlueYard, Eli Lilly, Genentech, Millipore Sigma, Pillar; (silver) Biocom California, Breakout Ventures, Cromatic, Molecule, Schrodinger; and philanthropic support from Lyda Hill Philanthropies, and Schmidt Futures. Visit for our regional sponsors and more information.